Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
MedTech
J&J trials IVL-first strategy in women with blocked coronaries
The trial tested Shockwave Medical's vessel-clearing approach as the primary procedure for women with calcified blockages in the coronary arteries.
Conor Hale
May 20, 2025 11:45am
Stylus outlines next-gen gene editing mission with $85M in hand
May 13, 2025 7:00am
J&J gene therapy fails ph. 3 rare eye disease trial
May 5, 2025 11:33am
HistoSonics considering a sale to major medtechs: report
May 2, 2025 11:30am
Next-gen pulsed field ablation comes to the fore at HRS
Apr 27, 2025 1:15pm
J&J calls time on Addex partnership a year after epilepsy fail
Apr 17, 2025 7:05am
